Martin Lauss Selected Research

Martin Lauss Research Topics

26	Melanoma (Melanoma, Malignant) 04/2024 - 08/2012
23	Neoplasms (Cancer) 03/2022 - 12/2007
3	Tertiary Lymphoid Structures 01/2022 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 02/2016 - 07/2008
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Sarcoma (Soft Tissue Sarcoma) 11/2020
1	Cutaneous Malignant Melanoma 01/2020
1	Genomic Instability 02/2016
1	Disease Progression 07/2015
1	Inflammation (Inflammations) 01/2015
1	Lung Neoplasms (Lung Cancer) 12/2014
1	Adenocarcinoma 12/2014
1	Adenocarcinoma of Lung 09/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2013
1	Carcinoma (Carcinomatosis) 01/2012
1	Thyroid Neoplasms (Thyroid Cancer) 12/2007

5	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 05/2014
5	Biomarkers (Surrogate Marker)IBA 03/2022 - 02/2012
5	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2007
4	Microphthalmia-Associated Transcription FactorIBA 10/2022 - 07/2015
3	Transcription Factors (Transcription Factor)IBA 10/2022 - 03/2020
3	Phenobarbital (Luminal)FDA Link 02/2016 - 02/2012
2	Histocompatibility Antigens Class IIBA 04/2024 - 01/2017
2	CytokinesIBA 01/2021 - 01/2015
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	A 121IBA 01/2021
1	VemurafenibIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	cyclopropapyrroloindoleIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	RNA Helicases (RNA Helicase)IBA 01/2019
1	DEAD-box RNA HelicasesIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	AntigensIBA 01/2017
1	ChromatinIBA 02/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	TensinsIBA 01/2016
1	InterferonsIBA 01/2015
1	AntibodiesIBA 08/2014
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	Phosphotransferases (Kinase)IBA 09/2013
1	Cadherins (E-Cadherin)IBA 09/2013
1	tyrosine receptor (receptor, tyrosine)IBA 09/2013
1	Keratin-5 (Keratin 5)IBA 09/2013
1	Complement System Proteins (Complement)IBA 06/2012
1	N-acetyltransferase 1IBA 02/2012
1	Estrogen ReceptorsIBA 02/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	4-O-carboxymethylascochlorinIBA 04/2011
1	P-2 (P 2)IBA 07/2008

10	Therapeutics 03/2022 - 12/2014
9	Immunotherapy 03/2022 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Molecular Targeted Therapy 05/2015
1	Precision Medicine 05/2014